Skip to main content

loratadine

Generic: LORATADINE·Brand: ALAVERT, Alavert, Alavert D, Allerclear, CHILDREN'S CLARITIN, CLARITIN, CLARITIN HIVES RELIEF, CLARITIN HIVES RELIEF REDITAB, CLARITIN REDITABS, Claritin, Claritin-D, Cleartime Indoor & Outdoor Allergies, LORATADINE, LORATADINE REDIDOSE, Loradamed, Tavist Non-Sedating, Wal-itin, Wal-itin D, Wal-vert

loratadine: 3 clinical trials tracked.

loratadine evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about loratadine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 3 study sponsors
Clinical Trials (3)

Prevent Allergic Reactions to Aphexda With Dexamethasone (PARADE)

NCT07101445·Phase 4·FLNA
Recruiting

Primary endpoint: Incidence and severity of systemic reactions

InterventionalRandomizedtriple94 targetStarted 2025-09Completion 2027-121 site · United StatesEmory University

A Phase 1, Randomized, Open-label, Parallel, Single-dose Study to Assess the Pharmacokinetics, Tolerability, and Absolute Bioavailability of Subcutaneous Administration of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Healthy Participants

NCT06955741·Phase 1·PRTA
Completed

Primary endpoint: Geometric Mean Ratio (GMR) of Maximum Observed Serum Concentration (Cmax) of BMS-986446 Administered IV versus SC

InterventionalRandomizedopen46 enrolledStarted 2025-05Completion 2025-092 sites · United StatesBristol-Myers Squibb

A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE Infusion

NCT06019728·Phase 4·SNY
Completed

Primary endpoint: Percent Reduction in Shortest Tolerated Infusion Duration From Pre-study Average of Recent 3 Infusions

Interventionalopen8 enrolledStarted 2023-11Completion 2024-105 sites · United StatesSanofi